ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

N4P N4 Pharma Plc

0.80
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma Plc LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.80 0.75 0.85 0.80 0.80 0.80 30,000 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 0 -1.03M -0.0057 -1.40 1.45M
N4 Pharma Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 0.80p. Over the last year, N4 Pharma shares have traded in a share price range of 0.625p to 2.00p.

N4 Pharma currently has 181,080,349 shares in issue. The market capitalisation of N4 Pharma is £1.45 million. N4 Pharma has a price to earnings ratio (PE ratio) of -1.40.

N4 Pharma Share Discussion Threads

Showing 7001 to 7024 of 8600 messages
Chat Pages: Latest  284  283  282  281  280  279  278  277  276  275  274  273  Older
DateSubjectAuthorDiscuss
01/9/2020
22:15
It’s going to save us all from Covid 19....but hasn’t even been injected into a human yet! There really wouldn’t be any point going into mass production....
nobbygnome
01/9/2020
22:10
Shouldn't it be revenue generating by now? Only so much 'optimisation' they can fob people off with before everyone realises nobody is going to use it. Chances of it being used in a covid vaccine are basically zero at this stage..
dplewis1
01/9/2020
20:32
Shouldn't that be a step towards optimisation for coming mass production?
mahmoudalkhatib
01/9/2020
17:52
dplewis1

I obtained shares in this company after my favourite share in the world, not really!! Ultima networks(not a company to bet your house on. gave me certificates to a shell company . Fingers crossed N4P might get my money back.

barrie16
01/9/2020
16:38
No problem Barrie I don't take offence at people asking questions unlike some people on these boards. I hold N4 in my 'punt portfolio' which has a couple of blue sky pharma names and some longshot tech stuff. Certainly not companies to bet the house on but worthwhile to have a few in case they magically hit the jackpot.
dplewis1
01/9/2020
15:54
Lovely wedge forming here on the chart.
jibba jabber
01/9/2020
14:47
dplewis1

I apologise if I appear to question you. I automatically assume people hold shares in a particular company, because they are positive for the future of that company. I personally don't hold shares in companies I don't have faith in.

barrie16
01/9/2020
13:47
Failed pump
newtoaim
01/9/2020
11:42
https://www.bloomberg.com/press-releases/2020-01-09/gho-capital-acquires-ardena-a-leading-cdmo-providing-early-stage-drug-development-and-manufacturing-for-small-to-mid-sizedArdena is a multi-service CDMO, assisting small-to-mid sized biopharma withservices spanning the full development life cycle. The Company offers acomprehensive 'Make, Analyse, File' model from drug substance and drug productmanufacturing and bioanalytical services through to regulatory dossierdevelopment. Headquartered in Belgium, the company operates across severalsites in the Netherlands, Sweden and Latvia.With a strong reputation for quality and a flexible service delivery model,Ardena caters to a highly diversified base of over 300 customers throughoutEurope, the US, Japan and Korea. A high science approach and broad drugdevelopment toolkit differentiate Ardena from peers as a comprehensivemulti-service pan-European platform.With extensive sectoral expertise and network in the global biopharmaindustry, the GHO team will support management in accelerating Ardena's planto enable customers to take a molecule from 'target to clinic' with a singleoutsourced drug development service provider.GHO plans to further strengthen Ardena's broad service proposition throughorganic and inorganic opportunities, adding to both the Company's offering andinternational footprint.The Company is well-positioned to benefit from sector trends as an increasingnumber of biopharma companies outsource large parts of their early stage drugdevelopment work to highly specialised CDMOs.Harry Christiaens, CEO of Ardena, commented: "With their deep expertise in thePharma sector, we are excited now to partner with GHO as we continue ourinternational growth. Ardena and GHO are fully committed to the science-ledapproach that delivers valuable solutions for our biopharma customersglobally."
ch1rp
01/9/2020
11:25
Yes the worse the zealotry, the more insecure the shareholders and the more dodgy the company is IMHO. I have increasingly noticed this trend on the BB recently.

The zealots here are some of the worst; need I say more.....

nobbygnome
01/9/2020
09:35
And I've never understood this attitude that people have where you're not allowed to express dissatisfaction at companies in which you hold shares. We don't live in the DPRK.. Nigel is not the dear leader.
dplewis1
01/9/2020
09:29
I've held shares on and off since the IPO but do currently hold
dplewis1
01/9/2020
09:20
dplwis1

You appear quite negative in respect of this company. Do you hold any shares in N4Pharma.

barrie16
01/9/2020
08:31
Agree. Excellent RNS.
jimbob999
01/9/2020
08:14
Looking like the solid base of 12p will be blown for higher highs with this news DP. Upscaling and certification of Nuvec for medical trials and partners is serious good news:)))
ch1rp
01/9/2020
07:27
Nigel Theobald, Chief Executive Officer, commented: "We are delighted to be working with Ardena as our tech transfer and manufacturing partner. As we look to continue the advancement of Nuvec® and its applications it is increasingly important that we have access to a consistent Nuvec® product across our studies together with the potential to move to GMP certification as and when required and Ardena can provide this."
ch1rp
01/9/2020
07:26
More good news. All coming together.
the drewster
01/9/2020
07:24
Establish an understanding of the current manufacturing process..? Blimey are they still piddling about with that??
dplewis1
01/9/2020
07:14
Rns out..N4 Pharma plc ("N4 Pharma" or the "Company") Technology Transfer and Manufacturing Contract N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing, a novel delivery system for cancer treatments and vaccines, announces that it has appointed the API and Nanomedicines business unit of Ardena ('Ardena') as its contract development and manufacturing organisation ('CDMO') partner for the technology transfer and upscaling manufacture of Nuvec®.
tp6
28/8/2020
13:05
that's it no more cheap shares, WINS has gone to 12p again

12p 30,000 WINS 13:00

master rsi
28/8/2020
12:57
Able to buy at middle price 11.675p ( 11.50 v 11.75p )

Only WINS at offer
2 at bid

master rsi
28/8/2020
12:54
Yes that 12p base looking solid just like Ch1rp said it would.. lol
dplewis1
28/8/2020
11:56
Consolidating nicely up here.
jibba jabber
28/8/2020
10:39
Someone bought big time yesterday at 12.5p and only now showing. Sit tight. At this rate we will eventually start to see the predicted rise:)))
ch1rp
Chat Pages: Latest  284  283  282  281  280  279  278  277  276  275  274  273  Older

Your Recent History

Delayed Upgrade Clock